• Accueil >
  • Publications >
  • Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours

1 janv. 2018Pharmacology & Therapeutics

DOI : 10.1016/j.pharmthera.2017.07.006

Auteurs

Cindy Neuzillet, Louis de Mestier, Benoît Rousseau, Olivier Mir, Mohamed Hebbar, Hemant M. Kocher, Philippe Ruszniewski, Christophe Tournigand